Key Stocks to Watch This Thursday: Akwel, Boiron, Genfit, and 7 Other Results
This Thursday, ten listed companies are on the schedule with annual results or revenue announcements. Here's an overview of the stocks to watch before the market opens.
Akwel reveals its annual results for 2025 this morning, with the stock closing the previous day at 7.10 euros, showing a slight increase. The automotive supplier, specialized in fluid management systems, operates in a sector that has been under significant pressure for several quarters due to the electric transition and the reconfiguration of supply chains.
Boiron also presents its annual accounts for 2025 today, with the homeopathic laboratory's share price up sharply by 2.59% at the last session, at 27.70 euros. The family-owned company from Lyon, which has undergone a deep transformation of its model in recent years due to the non-reimbursement of homeopathy in France, will be closely watched for its margins and the evolution of its international sales.
In the wooden construction sector, Wood Constructors revealed its annual results for 2025 yesterday, with a spectacular leap in its share price of 11.67% during the session to 2.68 euros—a sign of a publication well received by the market. Specializing in timber frame construction, the company capitalizes on a growing demand for bio-sourced materials in the construction sector.
Delta Plus Group, a manufacturer of personal protective equipment, presented its annual results for 2025 last night, in a context of a 1.69% decline in its share price to 40.60 euros. An international player present in over a hundred countries, the group is expected to focus on the dynamics of its acquisitions and the evolution of its positions in Asia and North America.
In biotech, Fermentalg publishes its annual accounts for 2025 today, after a session marked by a 10.04% increase in its share price to 0.537 euro. The Bordeaux-based company, a pioneer in the production of microalgae for food and industrial use, remains in a development phase and its investors will be attentive to the evolution of its cash flow and the schedule of its commercial partnerships.
Still in the life sciences realm, Genfit unveils its annual results for 2025 today, with the stock having risen by 1.77% to 8.63 euros in the last session. The Lille-based biotech, now focusing on rare liver diseases and biliary pathologies, is awaited on the progress of its clinical trials and the state of its financing.
Odyssée Techno published its annual results for 2025 yesterday, with a slight decrease in its share price by 0.74% to 27.00 euros at close. This company specialized in technological solutions remains little followed, but its annual accounts will allow an appreciation of its organic growth trajectory.
In the animation sector, Xilam Animation presents its annual results for 2025 this morning, with the stock showing a decline of 0.72% to 2.76 euros in the last session. The Parisian studio, creator of Oggy and the Cockroaches and Miraculous, is going through a strategic repositioning phase in response to the consolidation of global streaming platforms.
Finally, Argan revealed its first quarter 2026 revenue yesterday, with the stock up 3.01% to 58.10 euros at close. The real estate company, specialized in high-end logistic warehouses, whose portfolio is rented to major players in retail and e-commerce, will be scrutinized for the progression of its rents and the advancement of its development pipeline.
